New Approved Treatments for Geographic Atrophy: Insights
Available from: 5/05/2026 (AEST)
Where to publish: www.mieducation.com
Provider: Mivision
Contact: Nikki Byrne, [E] nikki@mivision.com.au, [P] 02 8336 8616
Activity Outline
There are now two approved treatments available in Australia for foveal-sparing geographic atrophy (GA) secondary to age-related macular degeneration (AMD), evidenced by progression. This article explores what this means for clinicians and patients.
Learning Objectives
- Understand the primary characteristics of geographic atrophy (GA) and the primary goal of current treatments
- Be aware of the different pathways targeted by current GA treatments
- Understand which patients are most likely to benefit from GA treatments
Max CPD hours awarded: 1
Session Information
| Name |
|---|
| New Approved Treatments for Geographic Atrophy: Insights |
| Clinical? |
| Yes |
| Interactive? |
| No |
| Therapeutic? |
| Yes |
| Duration of CPD Session/Module |
| 0.5 |
| Duration of CPD Session/Module inclusive of Assessment Component |
| 1 |